News

Polyvascular disease, defined as the presence of atherosclerotic disease involving ≥2 vascular beds (coronary, peripheral, or cerebrovascular), is common among patients with PAD and has recently ...
Graves’ disease, an autoimmune disorder leading to hyperthyroidism. Explore its causes, symptoms, diagnosis, and treatment options through expert guidance from WebMD.
Complex illnesses are not caused by one gene but groups of genes. The number of gene combinations is too enormous to analyze comprehensively. New AI model focuses on gene expression changes to ...
As the University of Minnesota's Center for Infectious Disease Research and Policy shared in mid-May, five South American countries confirmed 212 cases of yellow fever and 85 deaths related to the ...
Otsuka's experimental therapy for a potentially life-threatening kidney disease more than halved severe levels of protein in the urine of patients, intensifying the battle for an effective new ...
Huey Lewis chats with PEOPLE about his journey with Ménière's disease, saying that although the condition has caused hearing loss and changed major aspects of his life, he remains goal-oriented ...
But it's "essential" to properly diagnose thyroid disease before starting therapy, urged accompanying editorial author James V. Hennessey, MD, of Beth Israel Deaconess Medical Center in Boston ...
An urgent warning has been issued following the discovery of world's most infectious disease at America's largest shopping mall. Health officials have revealed that a child who visited the Mall of ...
HHS plans to fold the CDC's chronic disease center into the new Administration for a Healthy America. Experts fear for coordination with local health departments, among other things.
A-ha’s Morten Harket revealed Wednesday that he has been diagnosed with Parkinson’s disease, which could impact the “Take on Me” singer’s powerful voice and “creative future ...
Morten Harket, the lead singer of the Norwegian synth-pop band a-ha, best known for its 1985 hit single “Take on Me,” said Wednesday that he had Parkinson’s disease.
Under the new leadership, the FDA will “rapidly make available” rare disease drugs, Prasad said, and make use of surrogate endpoints to get new medicines to patients before they clear the traditional ...